Skip to main content
Premium Trial:

Request an Annual Quote

Ingenuity, Covance Form NGS Data-Analysis Collaboration

Premium

Ingenuity Systems said this week that it will partner with Covance Genomics to use Ingenuity's IPA software "to obtain more actionable insights from next-generation sequence data" as well as to "answer research questions in a relevant biological context."

Financial terms of the agreement were not disclosed.

In a statement, Tom Turi, vice president of science and technology in Covance' discovery and translational services group, said that the partners are "confident the combination of our … genomics data and the … biological content and context provided by IPA will result in the delivery of more rapid, accurate, and thorough research services for our customers."

The partnership with Covance marks Ingenuity's second NGS-focused partnership this year.

In January, the firm inked a deal with Erasmus Medical Center allowing the center to use IPA and Ingenuity Knowledgebase to map and contextualize genes and variants related to biological processes, functions, diseases, pathways, compounds, and relationships to "obtain a more complete biological picture from the data." (BI 01/21/2011)

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more